BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4695669)

  • 1. Characteristics of D-lysergic acid diethylamide binding to subcellular fractions derived from rat brain.
    Farrow JT; Van Vunakis H
    Biochem Pharmacol; 1973 May; 22(9):1103-13. PubMed ID: 4695669
    [No Abstract]   [Full Text] [Related]  

  • 2. Binding of d-lysergic acid diethylamide to subcellular fractions from rat brain.
    Farrow JT; Van Vunakis H
    Nature; 1972 May; 237(5351):164-6. PubMed ID: 4555508
    [No Abstract]   [Full Text] [Related]  

  • 3. The subcellular distribution of lysergic acid diethylamide in the rat brain.
    Faragalla FF
    Experientia; 1972 Dec; 28(12):1426-7. PubMed ID: 4654194
    [No Abstract]   [Full Text] [Related]  

  • 4. Subcellular distribution of delta9-tetrahydrocannabinol in rat brain.
    Colburn RW; Ng LK; Lemberger L; Kopin IJ
    Biochem Pharmacol; 1974 Feb; 23(4):873-7. PubMed ID: 4824510
    [No Abstract]   [Full Text] [Related]  

  • 5. d-LSD binding to brain homogenates: possible relationship to serotonin receptors.
    Bennett JL; Aghajanian GK
    Life Sci; 1974 Dec; 15(11):1935-44. PubMed ID: 4620998
    [No Abstract]   [Full Text] [Related]  

  • 6. High-affinity binding of (3H) 5-hydroxytryptamine to brain synaptosomal membranes: comparison with (3H) lysergic acid diethylamide binding.
    Fillion GM; Rousselle JC; Fillion MP; Beaudoin DM; Goiny MR; Deniau JM; Jacob JJ
    Mol Pharmacol; 1978 Jan; 14(1):50-9. PubMed ID: 625289
    [No Abstract]   [Full Text] [Related]  

  • 7. Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors.
    Bennett JP; Snyder SH
    Mol Pharmacol; 1976 May; 12(3):373-89. PubMed ID: 6896
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on enzymatic dealkylation of D-lysergic acid diethylamide (LSD).
    Niwaguchi T; Inoue T; Nakahara Y
    Biochem Pharmacol; 1974 Mar; 23(6):1073-8. PubMed ID: 4151050
    [No Abstract]   [Full Text] [Related]  

  • 9. Blockage of LSD binding at its high affinity site on synaptosomal membranes by 1-methyl-1,2,5,6-tetrahydropyridine-N,N-diethyl- carboxamide.
    Christian ST; McClain LD; Morin RD; Benington F
    Experientia; 1975 Aug; 31(8):910-11. PubMed ID: 125655
    [No Abstract]   [Full Text] [Related]  

  • 10. Binding of atropine and muscarone to rat brain fractions and its relation to the acetylcholine receptor.
    Farrow JT; O'Brien RD
    Mol Pharmacol; 1973 Jan; 9(1):33-40. PubMed ID: 4685450
    [No Abstract]   [Full Text] [Related]  

  • 11. 5-Hydroxytryptamine binding to synaptic membranes from rat brain.
    Fillion G; Fillion MP; Spirakis C; Bahers JM; Jacob J
    Life Sci; 1976 Jan; 18(1):65-74. PubMed ID: 2829
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of lysergic acid diethylamide on the uptake and retention of brain 5-hydroxytryptamine in vivo and in vitro.
    Ziegler MG; Lovell RA; Freedman DX
    Biochem Pharmacol; 1973 Sep; 22(17):2183-93. PubMed ID: 4270151
    [No Abstract]   [Full Text] [Related]  

  • 13. Stereospecific receptor sites for d-lysergic acid diethylamide in rat brain: effects of neurotransmitters, amine antagonists, and other psychotropic drugs.
    Lovell RA; Freedman DX
    Mol Pharmacol; 1976 Jul; 12(4):620-30. PubMed ID: 8700
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibitory effects of lysergic acid derivatives and reserpine on 5-HT binding to nerve ending particles.
    Marchbanks RM
    Biochem Pharmacol; 1967 Oct; 16(10):1971-9. PubMed ID: 6065963
    [No Abstract]   [Full Text] [Related]  

  • 15. Actions of hallucinogens on ants (Formica pratensis)--I. Brain levels of LSD and the following oral administration.
    Frischknecht HR; Waser PG
    Gen Pharmacol; 1978; 9(5):369-73. PubMed ID: 700356
    [No Abstract]   [Full Text] [Related]  

  • 16. The in vitro identification of dimethyltryptamine (DMT) in mammalian brain and its characterization as a possible endogenous neuroregulatory agent.
    Christian ST; Harrison R; Quayle E; Pagel J; Monti J
    Biochem Med; 1977 Oct; 18(2):164-83. PubMed ID: 20877
    [No Abstract]   [Full Text] [Related]  

  • 17. The action of some neuro- and psychopharmacological agents on the membrane ATP-ase of cortical synaptosomes.
    Waser PG; Schaub E
    Adv Cytopharmacol; 1971 May; 1():397-400. PubMed ID: 4271025
    [No Abstract]   [Full Text] [Related]  

  • 18. 5-HT and LSD high affinity binding sites to brain synaptosomal membranes [proceedings].
    Fillion G; Fillion MP; Jacob J; Rousselle JC
    Br J Pharmacol; 1976 Nov; 58(3):425P-426P. PubMed ID: 990612
    [No Abstract]   [Full Text] [Related]  

  • 19. Partial purification and characterization of a muscarinic acetylcholine receptor from rat cerebral cortex.
    Bartfai T; Anner J; Schultzberg M; Montelius J
    Biochem Biophys Res Commun; 1974 Jul; 59(2):725-33. PubMed ID: 4853542
    [No Abstract]   [Full Text] [Related]  

  • 20. Accumulation of chlorporomazine by subcellular fractions of rat brain.
    Phillips E; Livingston A
    Gen Pharmacol; 1976 Sep; 7(4):293-8. PubMed ID: 10227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.